A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups
NCT ID: NCT06145230
Last Updated: 2024-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
430 participants
OBSERVATIONAL
2023-12-12
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Screening for Hereditary Colorectal Cancer in China
NCT03365986
Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
NCT04947930
The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer
NCT03923335
the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT04074538
Evaluation of Some Risk Factors Associated With Colorectal Cancer
NCT05170360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Under 60 group
Colorectal cancer paitents aged under 60 years old ( do not include 60 years old)
60-69 group
Colorectal cancer paitents aged 60-69 years old
70-79 group
Colorectal cancer paitents aged 70-79 years old
80 and over group
Colorectal cancer paitents aged 80 and over 80 years old
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Undergoing surgical treatment of the primary lesion;
3. Voluntary participation of patients.
Exclusion Criteria
2. Patients did not receive surgical treatment or did not undergo pathologic examination
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wang Guiyu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wang Guiyu
Director of the Department of Colorectal Cancer Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ye Tian, Prof.
Role: STUDY_CHAIR
Second Affiliated Hospital of Harbin Medical University Ethics Committee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2ndHarbinMUSUV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.